Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack(TM) Kits
(NasdaqGM:HROW), NASHVILLE, Tenn., Feb. 17, 2026 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of a new Direct-to-Prescriber (DTP) cash-pay offering called PharmaPack, which expands the Company's commitment to offering affordable FDA-approved branded products as alternatives to off-label compounded formulations. PharmaPack kits […]